-
Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency.
Sebire NJ, Noble PL, Psarra A, Papapanagiotou G, Nicolaides KH.
BJOG 1996;103:887-90. -
The prevalence of non-viable pregnancy at 10-13 weeks of gestation.
Pandya PP, Snijders RJ, Psara N, Hilbert L, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:170-3. -
Down's syndrome screeening in the UK.
Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S, Reynolds TM.
Lancet 1996;347:906-7. -
Comparison of chorion villus sampling and early amniocentesis for karyotyping in 1,492 singleton pregnancies.
Nicolaides KH, Brizot ML, Patel F, Snijders R.
Fetal Diagn Ther 1996;11:9-15. -
Total amount of circulating human chorionic gonadotrophin alpha and beta subunits in first trimester trisomies 21 and 18.
Jauniaux E, Nicolaides KH, Nagy AM, Brizot M, Meuris S.
J Endocrinol 1996;148:27-31. -
Fetal heart rate and umbilico-placental Doppler flow velocity waveforms in early pregnancies with a chromosomal abnormality and/or an increased nuchal translucency thickness.
Jauniaux E, Gavrill P, Kuhn P, Kurdi W, Hyett J, Nicolaides KH.
Hum Reprod 1996;11:435-9. -
Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency.
Hyett JH, Sebire NJ, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:101-3. -
Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation.
Hyett JA, Noble PL, Snijders RJ, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:239-44. -
Abnormatlities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation.
Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:245-50. -
Fetal hepatic alpha-fetoprotein mRNA expression in fetuses with trisomy 21 and 18 at 12-15 weeks gestation.
Brizot ML, Mckie AT, von-Kaisenberg CS, Farzaneh F, Nicolaides KH.
Early Hum Dev 1996;44:155-9. -
Placental mRNA expression of alpha and beta human chorionic gonadotrophin in early trisomy 18 pregnancies.
Brizot ML, Jauniaux E, Mckie AT, Farzaneh F, Nicolaides KH.
Mol Hum Reprod 1996;2:463-5. -
Gene expression of human pregnancy-associated plasma protein-A in placenta from trisomic pregnancies.
Brizot ML, Hyett JA, Mckie AT, Bersinger NA, Farzaneh F, Nicolaides KH.
Placenta 1996;17:33-6. -
Maternal serum concentrations of pregnancy associated plasma protein A and pregnancy specific B-1 glycoprotein in multifetal pregnancies before and after fetal reduction.
Abbas A, Sebire NJ, Johnson M, Bersinger N, Nicolaides KH.
Hum Reprod 1996;11,900-2. -
Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation.
Snijders RJ, Sebire NJ, Souka A, Santiago C, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;6:250-5. -
Fetal exomphalos at 11 to 14 weeks of gestation.
Snijders RJ, Brizot ML, Faria M, Nicolaides KH.
J Ultrasound Med 1995;14:569-74. -
Maternal age and gestational age-specific risk for chromosomal defects.
Snijders RJ, Sebire NJ, Nicolaides KH.
Fetal Diagn Ther 1995;10:356-67. -
First trimester fetal nuchal translucency.
Pandya PP, Santiago C, Snijders RJ, Nicolaides KH.
Curr Opin Obstet Gynecol 1995;7:95-102. -
Natural history of trisomy 21 Fetuses with fetal nuchal translucency.
Pandya PP, Snijders RJM, Johnson S, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:381-3. -
Repeatability of measurement of fetal nuchal translucency thickness.
Pandya PP, Brizot ML, Altman D, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:334-7. -
The implementation of first trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
Pandya PP, Goldberg H, Walton B, Riddle A, Shelley S, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:20-5.